BeLite Medical Center

BeLite Medical Center operates as a medical weight loss clinic in Fairfax, Virginia, under the direction of Dr. Richard Rothman. The practice focuses exclusively on physician-supervised weight management programs that incorporate GLP-1 receptor agonist peptides as primary therapeutic agents. Located in Northern Virginia's Fairfax area, the clinic serves patients seeking medical intervention for obesity and metabolic health optimization through evidence-based pharmacotherapy combined with lifestyle modification protocols.

The clinic's treatment portfolio centers on three FDA-approved peptide medications: Liraglutide, Semaglutide, and Tirzepatide. Liraglutide functions as a GLP-1 receptor agonist that regulates appetite and glucose metabolism through daily subcutaneous injection. Semaglutide, available in weekly injection form, provides extended GLP-1 receptor activation with documented efficacy in clinical weight loss trials. Tirzepatide represents the newest addition to the treatment menu, functioning as a dual GIP/GLP-1 receptor agonist that targets multiple metabolic pathways simultaneously. Dr. Rothman and his clinical team evaluate each patient's medical history, current metabolic markers, and weight loss objectives to determine appropriate peptide selection and dosing protocols. The practice adjusts medication strength progressively based on patient tolerance and response metrics tracked throughout treatment.

Dr. Richard Rothman leads the medical team at BeLite Medical Center, bringing his clinical expertise to the design and oversight of individualized weight management programs. The practice employs nurse practitioners who conduct regular patient monitoring appointments, assess medication tolerance, and provide ongoing education about injection technique and side effect management. Clinical staff members review laboratory values, blood pressure readings, and body composition measurements at scheduled intervals to track metabolic improvements beyond scale weight. The medical team addresses patient questions about medication mechanisms, expected timelines for results, and strategies for maintaining weight loss after completing peptide therapy protocols.

Patients at BeLite Medical Center in Fairfax attend in-person consultations where providers gather comprehensive medical histories, perform physical examinations, and order baseline laboratory testing before initiating peptide therapy. Initial appointments include education about GLP-1 and GIP receptor agonist mechanisms, realistic weight loss expectations, potential side effects such as nausea or gastrointestinal changes, and injection administration training. Follow-up visits occur at intervals determined by the treatment protocol, typically ranging from bi-weekly to monthly, allowing providers to monitor progress and adjust dosing. The clinic provides patients with information about nutrition modifications and exercise recommendations that complement peptide therapy, though the primary intervention remains pharmacological. Staff members maintain communication channels for patients to report concerns or adverse effects between scheduled appointments.

BeLite Medical Center requires in-person attendance for all consultations and follow-up appointments at their Fairfax, Virginia location, ensuring direct provider-patient interaction throughout the treatment course. This model allows for hands-on assessment of injection sites, real-time vital sign measurement, and immediate clinical decision-making when dosage adjustments become necessary. The practice's focus on three specific peptide medications—Liraglutide, Semaglutide, and Tirzepatide—reflects a concentrated expertise in GLP-1 pathway therapeutics rather than a broad menu of unrelated treatments. Patients work with the same clinical team throughout their program, creating continuity in care delivery and familiarity with individual response patterns. The clinic's 4.8-star rating across 68 Google reviews indicates consistent patient satisfaction with the medical weight loss approach, provider communication, and program structure offered at this Northern Virginia facility.